Nonsteroidal mineralocorticoid receptor antagonists and cardiovascular events in type 2 diabetes: a retrospective study
Finerenone demonstrated superior cardiovascular outcomes compared with spironolactone and eplerenone in patients with T2DM with significant reductions in MACE, mortality, and heart failure events.
Authors
- Ming‐Hsien Tsai (ORCID: https://orcid.org/0000-0003-3561-4689)
- Yi‐Hsien Chen (ORCID: https://orcid.org/0000-0002-7019-2357)
- Yu-Wei Fang
- Mon‐Ting Chen
- Hung-Hsiang Liou
Institutions
- Fu Jen Catholic University (TW)
- National Taipei University of Nursing and Health Science (TW)
- Jen-Ai Hospital (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Municipal Jen-Ai Hospital (TW)
- Memorial Hospital (US)
Publication Details
- Journal
- European Heart Journal - Cardiovascular Pharmacotherapy
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1093/ehjcvp/pvaf048
- Citations
- 4
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 5.18
Funders
- Shin Kong Wu Ho-Su Memorial Hospital